Metolazone, >=98% (HPLC), solid

Metolazone, >=98% (HPLC), solid

Biochem/physiol Actions

Inhibitor of thiazide-sensitive Na+-Cl- cotransporter; antihypertensive; moderate "loop" diuretic.

Features and Benefits

This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Other Notes

Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. M1195.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573455 Metolazone, >=98% (HPLC), solid white 100 AQCHWTWZEMGIFD-UHFFFAOYSA-N 1S/C16H16ClN3O3S/c1-9-5-3-4-6-14(9)20-10(2)19-13-8-12(17)15(24(18,22)23)7-11(13)16(20)21/h3-8,10,19H,1-2H3,(H2,18,22,23) SIGMA-ALDRICH solid ≥98% (HPLC)
£767.46 (exc VAT) per 25MG
-
+
3573456 Metolazone, >=98% (HPLC), solid white 100 AQCHWTWZEMGIFD-UHFFFAOYSA-N 1S/C16H16ClN3O3S/c1-9-5-3-4-6-14(9)20-10(2)19-13-8-12(17)15(24(18,22)23)7-11(13)16(20)21/h3-8,10,19H,1-2H3,(H2,18,22,23) SIGMA-ALDRICH solid ≥98% (HPLC)
£192.21 (exc VAT) per 5MG
-
+